3028
0
09.03.2020 Novavax Analysis
The genetic sequence of the novel coronavirus that causes COVID-19 was published in the past month of February and many biotech firms have been scrambl
Yazar: Zack Smith
Yayınlanma: 10 Mart 2020 00:57
Güncellenme: 19 Kasım 2024 04:42
09.03.2020 Novavax Analysis
The genetic sequence of the novel coronavirus that causes COVID-19 was published in the past month of February and many biotech firms have been scrambling to make a vaccine and Novavax is one of the leading firms in developing the vaccine. On Friday it closed at $12.48which was 3.03% less of $12.87 Thursday closing. As the coronavirus has increased impact in the United States with more than 500 cases and 22 deaths confirmed, thousands of employees from Seattle to Silicon Valley have been reportedly told to work from home. Some public school districts in several states have shut down, universities are moving classes to online only to limit the spread. This is increasing pressure on the need for a vaccine and causing biotechs to continue soaring. As the market is closed Novavax is expected to go up with it pre-market price currently at $12.50.
İLGİLİ HABERLER
European stocks soared and focus shifted to German retail sales after Powell's speech!
Forex Signal For TRY/USD: Inflation Slowdown in November.
Forex Signal For GBP/USD: Bullish Trend Still Not Breaking While Recovery Continues.
Forex Signal For EUR/USD: Starry US Data Points to Higher Fed Increases.
Forex Signal For BTC/USD: Downside Continues as Bitcoin Recovery Moves Less.
En Popüler Haberler
Yorum Yap
Yorumlar
Henüz yorum yapan yok! İlk yorumu siz yapın...